June 25 – HHS and NIH are sponsoring meeting of the “Muscular Dystrophy Coordinating Committee for policy discussions” in Silver Spring, MD.
June 25-26 – Agency for Healthcare Research and Quality and FDA are holding a workshop, "Implementation of Risk-Minimization Action Plans (RiskMAPs) To Support Quality Use of Pharmaceuticals: Opportunities and Challenges," in Rockville, MD. This public workshop is intended to seek constructive input from a wide range of stakeholders, including clinicians, pharmacists, patients, third party payers of care, the pharmaceutical and biotechnology industries, researchers, and innovators in health information technology (HIT), to help in the development and implementation of mechanisms to minimize the risks of pharmaceuticals with unusual safety and patient monitoring concerns. This meeting is an initial step that is part of FDA's commitment to monitor the performance of RiskMAPs consistent with the goal articulated in the proposed PDUFA IV agreement to undertake regular follow up of these plans.
June 25-27 – National Foundation for Infectious Diseases presents their “Annual Conference on Antimicrobial Resistance” in Bethesda, MD. Featured presentations on drug resistant mycobacterium tuberculosis, rapid diagnostic technology, non-prescription antibiotics use, superbugs and severe infections, living in a microbial world, potential influences of therapy duration on resistance, and resistance and public policy
June 26-27 – HHS and NIH are holding a meeting of the National Children's Study (NCS) Advisory Committee to review the progress regarding the research plan and protocol, informed consent, adjunct studies and engaging health care providers in the NCS.
June 27 – Senate Special Committee on Aging is holding a meeting about the Doctor-Drug Industry Relationship. A full committee hearing on the relationship between doctors and the drug industry. Chairman Herb Kohl (D-WI) will chair a hearing titled "Paid to Prescribe?: Exploring the Relationship Between Doctors and the Drug Industry"
June 27 – Meeting of the FDA’s Pediatric Oncology Subcommittee of the Oncologic Drugs Committee.
June 28 – The Cato Institute presents “The Massachusetts Health Plan: A Progress Report.” The Massachusetts health care reforms signed into law in 2006 by then-governor Mitt Romney have become a point of contention among free-market advocates and in the Republican presidential campaign. David Hyman will present a new Cato Institute study, "The Massachusetts Health Plan: The Good, the Bad, and the Ugly," with comments by Ed Haislmaier, one of the chief architects of the Massachusetts health plan.